StonvexLoading…
StonvexStonvexStonvexCore line items from OXY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $21.57B | $22.71B | $23.23B | $36.23B |
Operating Income | $3.13B | $4.02B | $4.66B | $14.12B |
Net Income | $2.37B | $3.08B | $4.70B | $13.30B |
EPS (Diluted) | $1.61 | $2.44 | $3.90 | $12.40 |
Total Assets | $84.19B | $85.44B | $74.01B | $72.61B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.97B | $2.13B | $1.43B | $984.00M |
Free Cash Flow OCF − CapEx | $4.11B | $5.18B | $6.61B | $12.31B |
Shares Outstanding | 986.03M | 938.46M | 879.46M | 899.86M |